Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-16

Clinical Trial Update: A Study to Evaluate Efficacy and Safety of Distal Jejunal-release Dextrose Beads Formulation in Subjects With a Pathological Oral Glucose Tolerance Test [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy and safety of a distal jejunal-release dextrose beads formulation in adults with prediabetes and impaired glucose tolera…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Distal Jejunal-release Dextrose Beads Formulation

Snippet

Sponsor: Aphaia Pharma US LLC | Conditions: PreDiabetes, Glucose Tolerance Impaired | Phase 2 | Status: COMPLETED